JohnPolitesMDMS

Internal Medicine • Orlando, FL

Internal Medicine Resident

Join to view full profile

Dr. Polites is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Polites' full profile

Already have an account?

Office
52 W Underwood St
Orlando, FL 32806

Summary

General Surgery 2020-2021
Internal Medicine 2021-2024

Education & Training

Mercer University School of MedicineClass of 2020
Boston UniversityMS, Medical Sciences, Cum Laude, 2013 - 2015

Certifications & Licensure

FL State Medical License 2024 - 2026

Clinical Trials

A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes Start of enrollment: 2017 Jan 17
Completed
Phase 3
Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function Start of enrollment: 2016 Nov 28
Completed
Phase 3
Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment Start of enrollment: 2016 Nov 26
Completed
Phase 3
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved) Start of enrollment: 2017 Mar 02
Completed
Phase 3
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced) Start of enrollment: 2017 Mar 06
Completed
Phase 3
Clostridium Difficile Vaccine Efficacy Trial Start of enrollment: 2017 Mar 29
Completed
Phase 3
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to <26 Years of Age. Start of enrollment: 2017 Apr 24
Completed
Phase 3
A Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Naproxen for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip Start of enrollment: 2017 Aug 17
Completed
Phase 3
Join now to see all